These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30672615)

  • 1. Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy.
    Fujimura T; Kambayashi Y; Sato Y; Tanita K; Tono H; Lyu C; Takahashi T; Hashimoto A; Aiba S
    J Dermatol; 2019 Jul; 46(7):e260. PubMed ID: 30672615
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial.
    Carlino MS; Long GV; Schadendorf D; Robert C; Ribas A; Richtig E; Nyakas M; Caglevic C; Tarhini A; Blank C; Hoeller C; Bar-Sela G; Barrow C; Wolter P; Zhou H; Emancipator K; Jensen EH; Ebbinghaus S; Ibrahim N; Daud A
    Eur J Cancer; 2018 Sep; 101():236-243. PubMed ID: 30096704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary malignant melanoma of the nasal mucosa with orbital involvement. Case report].
    Gallotti M; Gencarelli G; Lancella A; Perinti A
    Acta Otorhinolaryngol Ital; 2002 Aug; 22(4):248-51. PubMed ID: 12379047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant melanoma of the nasal cavity.
    Going JJ; Kean DM
    J Laryngol Otol; 1989 Feb; 103(2):231-3. PubMed ID: 2926277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pembrolizumab for Recurrent Conjunctival Melanoma.
    Kini A; Fu R; Compton C; Miller DM; Ramasubramanian A
    JAMA Ophthalmol; 2017 Aug; 135(8):891-892. PubMed ID: 28715523
    [No Abstract]   [Full Text] [Related]  

  • 6. Pembrolizumab as first-line therapy in programmed death ligand 1-positive advanced lung cancer: Is it as effective as we think it is?
    Goldstein DA; Bilal U; Prasad V
    Cancer; 2017 Oct; 123(20):3872-3874. PubMed ID: 28662268
    [No Abstract]   [Full Text] [Related]  

  • 7. Unresectable Non-metastatic Primary Melanoma: Complete Remission Following Treatment with Anti-Programmed-cell-death-receptor 1.
    Lheure C; Hoffmann C; Kramkimel N; Plée J; Franck N; Vanhaecke C; Goldman-Lévy G; Bataillon G; Damotte D; Dupin N; Aractingi S; Grange F; Guégan S
    Acta Derm Venereol; 2019 Jan; 99(1):107-108. PubMed ID: 30176045
    [No Abstract]   [Full Text] [Related]  

  • 8. Complete and Sustained Response of Brain Metastases to Programmed Death 1 Antibody Monotherapy in Treatment-naive Programmed Death Ligand 1-Positive Lung Cancer.
    Varkaris A; Sehgal K; Rangachari D; Costa DB
    J Thorac Oncol; 2019 Feb; 14(2):e34-e36. PubMed ID: 30683297
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemohormonal therapy for malignant melanomas of the nasal and paranasal mucosa.
    Seo W; Ogasawara H; Sakagami M
    Rhinology; 1997 Mar; 35(1):19-21. PubMed ID: 9200258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti-PD-1.
    Thomas S; Laino A; Sturm R; Nufer K; Lambie D; Shepherd B; Atkinson V; Adams L; Soyer HP; Schaider H
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):e176-e177. PubMed ID: 29114959
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of High Neutrophil-to-Lymphocyte Ratio With Poor Outcomes of Pembrolizumab Therapy in High-PD-L1-expressing Non-small Cell Lung Cancer.
    Hasegawa T; Yanagitani N; Utsumi H; Wakui H; Sakamoto H; Tozuka T; Yoshida H; Amino Y; Uematsu S; Yoshizawa T; Uchibori K; Kitazono S; Horiike A; Horai T; Kuwano K; Nishio M
    Anticancer Res; 2019 Dec; 39(12):6851-6857. PubMed ID: 31810952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology quiz case 2. Primary mucosal melanoma of the nasal cavity.
    Calista D; Morri M; Riccioni L; Bassi M; Marchetti C
    Arch Otolaryngol Head Neck Surg; 2004 Apr; 130(4):475, 477-8. PubMed ID: 15096435
    [No Abstract]   [Full Text] [Related]  

  • 13. Coincident Metastatic Melanoma and Merkel Cell Carcinoma with Complete Remission on Treatment with Pembrolizumab.
    Thiem A; Kneitz H; Schummer P; Herz S; Schrama D; Houben R; Goebeler M; Schilling B; Gesierich A
    Acta Derm Venereol; 2017 Nov; 97(10):1252-1254. PubMed ID: 28761962
    [No Abstract]   [Full Text] [Related]  

  • 14. Metastatic melanoma.
    Steger CM; Mehmeti A; Fischler N
    BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 22949118
    [No Abstract]   [Full Text] [Related]  

  • 15. Case of acute-onset type 1 diabetes induced by long-term immunotherapy with nivolumab in a patient with mucosal melanoma.
    Maekawa T; Okada K; Okada H; Kado S; Kamiya K; Komine M; Murata S; Oka K; Ishibashi S; Ohtsuki M
    J Dermatol; 2019 Dec; 46(12):e463-e464. PubMed ID: 31436330
    [No Abstract]   [Full Text] [Related]  

  • 16. PD-1 Inhibitor Therapy: Consensus Statement From the Faculty of the Melanoma Nursing Initiative on Managing Adverse Events
.
    McGettigan S; Rubin KM
    Clin J Oncol Nurs; 2017 Aug; 21(4 Suppl):42-51. PubMed ID: 28738055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant melanoma of the nasal cavity treated with stereotactic radiotherapy using CyberKnife: report of 2 cases.
    Abe T; Ebara T; Miyaura K; Kumazaki Y; Nakahira M; Sugasawa M; Shikama N; Kato S
    Am J Otolaryngol; 2015; 36(2):306-9. PubMed ID: 25510209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Toxicity of Pembrolizumab in Pediatric Metastatic Recurrent Melanoma.
    Marjanska A; Galazka P; Marjanski M; Wysocki M; Styczynski J
    Anticancer Res; 2019 Jul; 39(7):3945-3947. PubMed ID: 31262925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma.
    Hamid O; Puzanov I; Dummer R; Schachter J; Daud A; Schadendorf D; Blank C; Cranmer LD; Robert C; Pavlick AC; Gonzalez R; Hodi FS; Ascierto PA; Salama AKS; Margolin KA; Gangadhar TC; Wei Z; Ebbinghaus S; Ibrahim N; Ribas A
    Eur J Cancer; 2017 Nov; 86():37-45. PubMed ID: 28961465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary mucosal malignant melanoma (PMMM) of nasal cavity: A report of two cases.
    Chaturvedi A; Mallya V; Mandal S; Khurana N; Meher R; Singh K
    J Cancer Res Ther; 2024 Apr; 20(3):1053-1056. PubMed ID: 39023618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.